TL;DR
This study provides a comprehensive, transcriptome-wide map of interactions between circular RNAs (circRNAs) and RNA-binding proteins (RBPs). They reveal that circRNA exons are generally enriched for RBP binding sites, suggesting a significant regulatory role for these interactions, and demonstrate cell-type-specific interactions with implications for cancer progression and patient survival.
What Problem Does This Paper Address?
Circular RNAs (circRNAs) are a fascinating class of RNA molecules that have gained attention for their stability and potential regulatory roles. While a few circRNAs have been shown to interact with RNA-binding proteins (RBPs), our understanding of the prevalence and functional significance of these interactions across different cellular contexts and diseases remains limited. This paper aims to bridge this knowledge gap by systematically investigating the global landscape of circRNA-RBP interactions and their functional consequences, particularly in the context of cancer.
Methods
The researchers employed a multi-pronged approach:
- Transcriptome-wide circRNA profiling: They used deep RNA sequencing data from ENCODE cell lines (HepG2 and K562) to identify and quantify circRNAs.
- RBP binding site analysis: They leveraged large-scale eCLIP (enhanced CLIP) datasets to map the binding sites of 150 RBPs across the transcriptome.
- Computational identification of circRNA-RBP interactions: They computationally identified circRNAs that were highly covered by RBP binding sites.
- Experimental validation: RNA immunoprecipitation (RIP) assays were used to experimentally confirm predicted circRNA-RBP interactions.
- Functional studies: siRNA-mediated knockdown of specific circRNAs and RBPs was performed to assess their effects on gene expression, cancer hallmarks, and signaling pathways (e.g., MAPK signaling).
- Clinical correlation analysis: They investigated the association between circRNA expression levels and patient survival in bladder cancer cohorts.
Datasets
- ENCODE cell lines: HepG2 and K562 cell lines were used for comprehensive profiling of circRNAs and RBP binding sites.
- eCLIP data: Large-scale eCLIP datasets for 150 RBPs were utilized to map RBP binding sites.
- Bladder cancer patient cohort: Data from a cohort of patients with non-muscle invasive bladder cancer was used for survival analysis.
Key Insights and Ideas
- CircRNAs are RBP hotspots: The study reveals that circRNA exons are significantly enriched with RBP binding sites compared to non-circularizing exons, suggesting that circRNAs act as preferential binding platforms for RBPs.
- KHSRP's role in circRNA biogenesis: They identified KHSRP as an RBP that binds to intronic regions flanking circRNAs and demonstrated that KHSRP depletion affects circRNA biogenesis, highlighting a novel regulatory mechanism.
- Cell-type specificity of interactions: The research emphasizes that circRNA-RBP interactions are highly cell-type specific, meaning that the same circRNA might interact with different RBPs in different cell lines or tissues.
- circCDYL as a key player: The study highlights circCDYL as a particularly interesting circRNA, highly expressed and extensively covered by RBP binding sites, with significant roles in cancer pathways and patient survival.
- circRNA-RBP interactions in cancer: The findings strongly suggest that circRNA-RBP interactions play crucial roles in cancer development and progression, influencing key cancer genes and pathways.
Key Results
- Widespread circRNA-RBP interactions: The study identified a vast number of circRNA-RBP interactions across the transcriptome.
- Enrichment of RBPs in circRNA exons: CircRNA exons showed significantly higher RBP coverage compared to linear exons, even in genes with similar expression levels.
- KHSRP depletion impacts circRNA expression: Knockdown of KHSRP led to a decrease in the expression of circRNAs with KHSRP binding sites in flanking introns.
- circCDYL interacts with GRWD1, IGF2BP1, and IGF2BP2: Experimental validation confirmed these interactions, with circCDYL showing cell-type-specific binding preferences.
- circCDYL KD affects cancer pathways: Depletion of circCDYL in HepG2 cells activated cancer-related pathways, including the MAPK signaling pathway.
- circCDYL and survival: Elevated levels of circCDYL were associated with better overall survival in bladder cancer patients.
Limitations and Future Work
- eCLIP data limitations: The eCLIP data was generated for linear transcripts, and while they attempted to map unmapped reads to BSJ sequences, direct detection of RBP binding at the BSJ of circRNAs was challenging due to short read lengths.
- Causality vs. correlation: While strong associations were found, further experiments are needed to definitively establish causality for all observed circRNA-RBP interactions in tumorigenesis.
- Mechanistic details: The precise mechanisms by which circRNAs regulate RBP localization, activity, and homeostasis require further investigation.
- Biomarker potential: The study suggests circCDYL's potential as a biomarker, but further validation in larger clinical cohorts is warranted.
- Therapeutic implications: The findings open avenues for exploring circRNA-RBP interactions as potential therapeutic targets in cancer.
Summary updated